Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years
Business Wire India Results from an interim analysis of the OLYMPIA long-term extension (LTE) study show that Nemluvio maintained long-term…